The healthcare world is seeing a significant shift in glucose management with the arrival of GLP-1 transdermal devices. These devices offer a possibly more user-friendly alternative to subcutaneous administrations of GLP-1 drugs, minimizing the frequency of daily needle pokes. The approach releases the drug directly through the skin, possibly impro